JAMA Medical News

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute. Related Content: Highlights From the ASCO Annual Meeting—New Approaches to Cancers of the Blood, Brain, Lung, and More

JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Debra Boyer, MD, MHPE, about important research studies and keynote addresses presented at the American Thoracic Society International Conference in May 2023. Dr Boyer is a pediatric pulmonologist and chief medical education officer at Nationwide Children's Hospital in Columbus, Ohio, and was cochair of this year's conference. Related Content: COPD Mortality, Goals-of-Care Conversations in Serious Illness, and Advocating for Climate Change Science and Gun Violence Prevention—Highlights From the American Thoracic Society Conference

What Clinicians Need to Know About "Tranq"; As Laws Restricting Health Care Surge, Some US Physicians Choose Between Fight or Flight Related Content: As Laws Restricting Health Care Surge, Some US Physicians Choose Between Fight or Flight Here's What to Know About Xylazine, aka Tranq, the Animal Tranquilizer Increasingly Found in Illicit Fentanyl Samples Risk of Parkinson Disease Among Camp Lejeune Veterans

JAMA Fishbein Fellow Revital Marcus, MD, talks with American Academy of Neurology president-elect and meeting science committee chair Natalia Rost, MD, about hot topics at this year's conference in Boston, including new Alzheimer disease drugs, long COVID and the central nervous system, and a nasal spray for migraines. Related Content: New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines—Highlights From the 2023 American Academy of Neurology Conference

More than 14 000 infectious diseases physicians, clinical microbiologists, and public health professionals gathered in Copenhagen, Denmark, in April for the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Europe's largest infectious diseases conference. In this Medical News Q&A, JAMA Deputy Editor Preeti N. Malani, MD, MSJ, discusses highlights from the congress with Jacob Moran-Gilad, MD, MPH, ECCMID program director. Related Content: Artificial Intelligence, Emerging Threats, and Diagnostic Advances—Highlights From ECCMID, Europe's Largest Infectious Disease Conference

As Ozempic's Popularity Soars, Here's What to Know About Semaglutide and Weight Loss; Implementation Science Seeks to Translate Research Into Practice; What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis Related Content: As Ozempic's Popularity Soars, Here's What to Know About Semaglutide and Weight Loss It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis

Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn't Become Law; The Debate Over Whether to Make Daylight Saving or Standard Time Permanent; Expanded Family Leave Policies May Ease Burden for Residents Related Content: Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn't Become Law Groundswell Grows for Permanent Daylight Saving Time, but Medical Societies Overwhelmingly Support Year-Round Standard Time Expanded Family Leave Policies May Ease Burden for Residents Cut Calories, Lengthen Life Span? Randomized Trial Uncovers Evidence That Calorie Restriction Might Slow Aging, but Questions Remain Highlights From the American College of Cardiology's 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C

JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Douglas Drachman, MD, about late-breaking research discussed at the annual conference of the American College of Cardiology and World Congress of Cardiology. Dr Drachman—who chaired this year's conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division. Related Content: Highlights From the American College of Cardiology's 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More

More than 2 million individuals in the US are chronically infected with hepatitis C, and nearly 15 000 die every year. Antivirals are available but are not reaching the majority of infected individuals. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Francis S. Collins, MD, PhD, discuss a plan to eliminate hepatitis C included in the Biden-Harris 2024 budget proposal. Related Content: A National Hepatitis C Elimination Program in the United States Eliminating Hepatitis C in the United States Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C After 12 Years, NIH Director Francis S. Collins, MD, PhD, Seeks His Next Chapter After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter

Conference clinical cochair Diane Havlir, MD, a professor of medicine at the University of California, San Francisco, sits down with JAMA Deputy Editor Preeti Malani, MD, MSJ, about research highlights presented at the 30th annual CROI, held in Seattle. The infectious disease experts discuss postexposure prophylaxis for sexually transmitted infections, a new protease inhibitor for COVID-19, goals for preventing HIV transmission, and more. Related Content: Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections—Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More